媒體:
233
建立:
2022/03/17
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA學術資訊組, TUA出納客服組, TUA會議組
  1. 知識庫
  2. ...
  3. 2022年會
  4. 摘要
  5. 媒體
管理者：系統管理者, TUA秘書處, TUA會計採購組, TUA學術資訊組, TUA出納客服組, TUA會議組
  1. 1.
    Podium
    1. 1.1
      PD01-1: A genome-wide association study (GWAS) of kidney stone disease in the Taiwanese population.
      人氣: 1430, 討論: 0, 發表人: TUA會計採購組, 上傳時間: 2022-06-07
    2. 1.2
      PD01-2: The sodium-glucose cotransporter-2 inhibitor dapagliflozin inhibit kidney stone formation through modulating AMPK-mediated autophagy
      人氣: 1196, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    3. 1.3
      PD01-3: Urine NT-probnp as a non-invasive indicator for recovery of renal function after receiving ureteroscopic surgery aiming at relieving hydronephrosis
      人氣: 983, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    4. 1.4
      PD01-4: Comparison of surgical outcomes between ultramini-endoscopic combined intrarenal surgery and retrograde intrarenal surgery
      人氣: 1106, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    5. 1.5
      PD01-5: Comparative analysis of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and retrograde intrarenal surgery in the management of large proximal ureteral calculi
      人氣: 1251, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    6. 1.6
      PD01-6: Comparison of mini endoscopic combined intrarenal surgery and multitract percutaneous nephrolithotomy specifically for kidney staghorn stones: A single-center experience
      人氣: 977, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    7. 1.7
      PD02-1: Mir-299-3p inhibits cell proliferation, motility and invasion through VEGFA in upper tract urothelial carcinoma
      人氣: 1218, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    8. 1.8
      PD02-2: The prognostic significance of ROR2 expression in patients with urothelial carcinoma
      人氣: 1228, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    9. 1.9
      PD02-3: Decreased Dehydrogenase/Reductase 2(DHRS2) expression is associated with poor prognosis in urothelial carcinoma patients
      人氣: 1189, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    10. 1.10
      PD02-04: Outcomes of chemotherapy agents as subsequent replacements for discontinued bacillus calmette-guerin bladder instillation in bladder cancer
      人氣: 1000, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    11. 1.11
      PD02-5: Predictive factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
      人氣: 1195, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    12. 1.12
      PD02-6: The therapeutic potential of chemoradiotherapy combine with regional hyperthermia therapy for locally advanced bladder cancer- phase III clinical trial preliminary data report
      人氣: 1259, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    13. 1.13
      PD03-01: The occurrence of inguinal hernia after robotic assisted radical prostatectomy: Clinical characteristics and associated risk factors
      人氣: 1033, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    14. 1.14
      PD03-02: Comparing the perioperative outcomes between hand-assisted laparoscopic partial nephrectomy and laparoscopic partial nephrectomy
      人氣: 1104, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    15. 1.15
      PD03-03: Outcome of robotic radical cystectomy with intracorporeal J-pouch neobladder in muscle-invasive bladder cancer patient
      人氣: 1071, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    16. 1.16
      PD03-04: Loss of MAEL expression sabotages mitochondrial function and impairs human sperm motility
      人氣: 1010, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    17. 1.17
      PD03-05: The relationship between antioxidative ingredients of traditional chinese medicine and semen quality in men with infertility
      人氣: 1036, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    18. 1.18
      PD03-06: Combining sperm DNA fragmentation index with computer-assisted semen morphokinematic parameters as a better window into male fertility
      人氣: 1072, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    19. 1.19
      PD04-01: Active surveillance in Taiwanese men with localized prostate cancer: Outcomes and predicting models
      人氣: 1087, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    20. 1.20
      PD04-02: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
      人氣: 1042, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    21. 1.21
      PD04-03: The role of urine metabolomics in predicting clinically significant prostate cancer
      人氣: 1047, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    22. 1.22
      PD04-04: Comparison of the clinical outcomes of chemotherapy and novel hormone agents in pre-chemotherapy and post-chemotherapy settings for treatment of metastatic castration-resistant prostate cancer
      人氣: 923, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    23. 1.23
      PD04-05: Prostate health index density outperforms prostate health index in clinically significant prostate cancer detection
      人氣: 1060, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    24. 1.24
      PD04-06: 4-year experience in cmuh for learning curve of MRI/Ultrasound fusion-guided prostate biopsy
      人氣: 1014, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    25. 1.25
      PD05-01: Clinical factors that influence the occurrence of renal artery pseudoaneurysms after robotic assisted partial nephrectomy: Single center study of renal function outcomes
      人氣: 993, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    26. 1.26
      PD05-02: Prognostic factors of disease progression in patients with locally advanced renal cell carcinoma
      人氣: 967, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    27. 1.27
      PD05-03: Early postoperative outcomes of retroperitoneal partial nephrectomy of anterior and posterior renal tumors: A five-year experience in a single center
      人氣: 970, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    28. 1.28
      PD05-04: The prevalence and association of complicated ureteral double-J stent exchange in patients with malignant ureteral obstruction: A single-center, 20 years retrospective study
      人氣: 1015, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    29. 1.29
      PD05-05: The safety and efficacy of endoscopic resection of bladder tumor with vela laser– a single center experience
      人氣: 1026, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    30. 1.30
      PD05-06: Does surgical experience influence the oncological outcome following hand-assisted or pure laparoscopic transperitoneal nephroureterectomy for primary upper urinary tract urothelial carcinoma in Taiwan
      人氣: 1331, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    31. 1.31
      PD06-01: The effect of hyper-sugar situation and LCN2 treatment to the uropathogenic escherichia coli infection and induced inflammation in bladder cells
      人氣: 1018, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    32. 1.32
      PD06-02: The reconstruction of severe type hypospadias with sandwich technique-sharing the experience of CCH in recent 30 years
      人氣: 959, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    33. 1.33
      PD06-03: Treatment response of nocturnal enuresis children: A study of interdepartmental prescription and responses in Taiwan
      人氣: 976, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    34. 1.34
      PD06-04: Deep fascia YV scrotoplasty for correcting buried penis in children
      人氣: 1030, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    35. 1.35
      PD06-05: Native hydronephrosis after kidney transplantation relates to urinary bladder urothelial carcinoma: A single center study
      人氣: 975, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    36. 1.36
      PD06-06: Comparing the different definition of delayed graft function after renal transplantation
      人氣: 1217, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    37. 1.37
      PD07-01: The effects of inhibition and activation of TMEM16A calcium-activated chloride channels on the smooth muscle tissue in metabolic syndrome induced overactive bladder and acontractile detrusor
      人氣: 928, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    38. 1.38
      PD07-02: Ebv-mediated BDNF expression in B cells is causally linked to the persistence of hic-induced pathogenesis
      人氣: 1045, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    39. 1.39
      PD07-03: Endoscopic intravesical repair as a feasible and promising approach for vesicovaginal fistula
      人氣: 1015, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    40. 1.40
      PD07-04: Therapeutic effect of low intensity extracorporeal shock wave therapy (Li-ESWT) on diabetic bladder dysfunction in a rat model
      人氣: 1210, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    41. 1.41
      PD07-05: Does COVID-19 vaccine deteriorate storage lower urinary tract symptoms?
      人氣: 990, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    42. 1.42
      PD07-06: The role of the angle of spinning top urethra in females with dysfunctional voiding
      人氣: 989, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    43. 1.43
      PD08-01: Comparison of bacterial cultures in urine and semen after prostate massage in patients with chronic prostatitis/chronic pelvic pain syndrome
      人氣: 1001, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    44. 1.44
      PD08-02: Therapeutic effects of low-intensity extracorporeal shock wave therapy on overactive bladder
      人氣: 1122, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    45. 1.45
      PD08-03: Concomitant detrusor and external urethral sphincter botulinum Toxin-A injections in male spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia
      人氣: 992, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    46. 1.46
      PD08-04: The role of plasma angiotensin-converting enzyme 2 in primary aldosteronism
      人氣: 993, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    47. 1.47
      PD08-05: New-onset Diabetic Mellitus Associated with Concurrent Autonomous Cortisol Secretion in Patients with Primary Aldosteronism
      人氣: 1102, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    48. 1.48
      PD08-06: Congenital Collagenopathy Increased the Risk of Inguinal Hernia－A Longitudinal Cohort Study
      人氣: 982, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    49. 1.49
      PD09-01: The real-world outcome with Abiraterone acetate plus prednisone in asian men with metastatic castrate-resistant prostate cancer treated in China Medical University Hospital
      人氣: 985, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    50. 1.50
      PD09-02: Preoperative MRI and clinical factors are predictors for biochemical recurrence in high and very high risk prostate cancer
      人氣: 989, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    51. 1.51
      PD09-03: Could 18F-FluciclovinePET/CT be a game changer in prostate cancer with biochemical recurrence?
      人氣: 988, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    52. 1.52
      PD09-04: Efficacy of immune check point inhibitors in metastatic urothelial carcinoma is associated with chemotherapy response, a real world retrospective study
      人氣: 1137, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    53. 1.53
      PD09-05: Perineural invasion can predict prognosis for upper tract urothelial carcinoma following radical nephroureterectomy
      人氣: 991, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    54. 1.54
      PD09-06: Initial antibiotics choice may not be associated with the prognosis of fournier’s gangrene
      人氣: 1020, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
  2. 2.
    Moderated Poster
    1. 2.1
      MP01-01: Can we use urinary biomarkers to identify occult detrusor overactivity in women with stress urinary incontinence?
      人氣: 920, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    2. 2.2
      MP01-02: Association with female stress urinary incontinence and sarcopenia defined by bioelectrical inpedance analysis
      人氣: 975, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    3. 2.3
      MP01-03: Transvaginal ultrasound shear wave elastography to evaluate detrusor wall of bladder pain syndrome in women: A preliminary report
      人氣: 900, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    4. 2.4
      MP01-04: Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding
      人氣: 958, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    5. 2.5
      MP01-05: Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction
      人氣: 948, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    6. 2.6
      MP01-06: Type D personality is a predictor of worse quality of life in women with non-neurogenic voiding dysfunction
      人氣: 913, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    7. 2.7
      MP01-07: Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification
      人氣: 877, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    8. 2.8
      MP01-08: Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics
      人氣: 993, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    9. 2.9
      MP01-09: Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system disorders- a cohort study
      人氣: 918, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    10. 2.10
      MP01-10: Mirabegron is more tolerable than solifenacin in sjogren’s syndrome patients with overactive bladder symptoms
      人氣: 1033, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    11. 2.11
      MP02-01: Robotic-assisted radical nephroureterectomy with bladder cuff excision using Da Vinci Xi Vs. Si System: Are there any differences?
      人氣: 1102, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    12. 2.12
      MP02-02: Laparoendoscopic single-site inguinal herniorrhaphy: Single-institute experience and the outcome comparison of obesity
      人氣: 985, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    13. 2.13
      MP02-03: Ureteral reconstruction for patient with ureteral stricture in more challenging situations
      人氣: 951, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    14. 2.14
      MP02-04: The application of hybrid or in the surgery for multiple-times recurrence of adrenal cortical carcinoma
      人氣: 898, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    15. 2.15
      MP02-05: The peak systolic velocity of the penile artery might indicate the risk of cardiovascular disease in patients with erectile dysfunction
      人氣: 975, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    16. 2.16
      MP02-06: The more veins ligated intraoperatively; the more pain improved postoperatively after microsurgical varicocelectomy
      人氣: 936, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    17. 2.17
      MP02-07: Investigating the clinical utility of three sperm chromatin dispersion (SCD) assays for sperm DNA fragmentation in male infertility
      人氣: 1156, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    18. 2.18
      MP02-08: An innovative combination of penile corporeal girth enhancement and erection restoration
      人氣: 1069, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    19. 2.19
      MP02-09: A better method to estimate ureter length in patient who needs DBJ stenting by a formula
      人氣: 990, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    20. 2.20
      MP02-10: Overall survival and techenque survival in elderly peritoneal dialysis patients
      人氣: 888, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    21. 2.21
      MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma
      人氣: 930, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    22. 2.22
      MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma
      人氣: 1115, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    23. 2.23
      MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma
      人氣: 884, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    24. 2.24
      MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study
      人氣: 948, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    25. 2.25
      MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma
      人氣: 1148, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    26. 2.26
      MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy
      人氣: 927, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    27. 2.27
      MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy
      人氣: 1044, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    28. 2.28
      MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer
      人氣: 855, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    29. 2.29
      MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study
      人氣: 935, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    30. 2.30
      MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients
      人氣: 886, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    31. 2.31
      MP04-01: A novel prediction of uric acid component in nephrolithiasis using simple clinical information: A machine learning-based model
      人氣: 1044, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    32. 2.32
      MP04-02: Genetic polymorphisms of MnSOD modify the impacts of environmental melamine on oxidative stress and early kidney injury in calcium urolithiasis patients
      人氣: 960, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    33. 2.33
      MP04-03: Analysis of renal hematoma after extracorporeal shock wave lithotripsy
      人氣: 906, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    34. 2.34
      MP04-04: The impact of climate factors on the prevalence of urolithiasis and the trend of the urinary stone disease management in southern Taiwan
      人氣: 892, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    35. 2.35
      MP04-05: Betel nut chewing is related to the risk of kidney stone disease
      人氣: 944, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    36. 2.36
      MP04-06: Can hounsfield unit of preoperative non-contrast computed tomography be used to predict calcium urinary stone composition?
      人氣: 981, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    37. 2.37
      MP04-07: The impact of secondhand smoke on the development of kidney stone disease is not inferior to that of smoking
      人氣: 910, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    38. 2.38
      MP04-08: Experimental observation of isolative efficacy of solid coupling medium in extracorporeal shock wave lithotripsy
      人氣: 916, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    39. 2.39
      MP04-09: Comparison of the clinical outcome and treatment cost of proximal ureteral stone removal requiring multiple initial ureteroscopic lithotripsy or extracorporeal shock wave lithotripsy procedures
      人氣: 930, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    40. 2.40
      MP04-10: Risk factors of infectious complications after retrograde intrarenal surgery with holmium laser for renal stones
      人氣: 949, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    41. 2.41
      MP05-01: Survival impact of nephroureterectomy for de novo stage IV (nonmetastatic and metastatic) upper tract urothelial carcinoma
      人氣: 903, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    42. 2.42
      MP05-02: Melatonin suppresses tumor malignancy through the NF-KB/P65/HIF-1a pathway in urothelial carcinoma
      人氣: 961, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    43. 2.43
      MP05-03: Influence of novel inflammatory biomarkers on prediction for patients with upper tract urothelial carcinoma
      人氣: 852, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    44. 2.44
      MP05-04: Effect of Metformin on overall survival of upper tract urothelial carcinoma in patients with type 2 diabetes
      人氣: 1218, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    45. 2.45
      MP05-05: Clinical outcomes of plasmacytoid urothelial carcinoma of urinary bladder: A single institution experience
      人氣: 1039, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    46. 2.46
      MP05-06: Validation of neutrophil to lymphocyte ratio for prognosis and treatment selection in muscle invasive bladder cancer: A single-institutional longitudinal study
      人氣: 980, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    47. 2.47
      MP05-07: Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
      人氣: 927, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    48. 2.48
      MP05-08: Efficiency and prognosis of enucleation turbt versus traditional turbt– VGHTC experience
      人氣: 928, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    49. 2.49
      MP05-09: Suppression of tumor characteristics of urothelial carcinoma cells by berberrubine and resveratrol by GSTM2 induction
      人氣: 888, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    50. 2.50
      MP05-10: Thrombospondin-4 induces lymphangiogenesis by lymphatic endothelial cell recruitment in bladder tumor
      人氣: 1111, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    51. 2.51
      MP06-01: Is extraperitoneal extended pelvic lymph node dissection adequate during robotic assisted radical prostatectomy for intermediate and high risk localized prostate cancer?
      人氣: 905, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    52. 2.52
      MP06-02: A single center experience of Abiraterone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel based chemotherapy
      人氣: 929, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    53. 2.53
      MP06-03: Real world experience of androgen deprivation therapy associated bone fracture risk in newly diagnosed prostate cancer patients
      人氣: 923, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    54. 2.54
      MP06-04: Hyperforin induces extrinsic/intrinsic apoptosis signaling and inhibits NF-кB for metastasis suppression in prostate cancer cells
      人氣: 1063, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    55. 2.55
      MP06-05: Retzius-sparing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for very high-risk prostate cancer
      人氣: 937, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    56. 2.56
      MP06-06: The analysis of concordance rates between cancer stage of MR/US fusion prostate biopsy and radical prostatectomy specimen
      人氣: 918, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    57. 2.57
      MP06-07: Oncological and functional outcomes in high risk and very high risk prostate cancer patients receiving robotic-assisted radical prostatectomy
      人氣: 926, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    58. 2.58
      MP06-08: Treatment strategy and systemic review with PSMA PET/CT scan in progressive advanced prostate cancer
      人氣: 1074, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    59. 2.59
      MP06-09: KCGMH experience and meta-analysis: 6-cycle complete rate of Radium-223 therapy in Mcrpc patients with different treatment sequences
      人氣: 904, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    60. 2.60
      MP06-10: Characteristics of mCRPC patients received Abiraterone acetate plus prednisolone and Enzalutamide before chemotherapy
      人氣: 969, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    61. 2.61
      MP07-01: The therapeutic effects of peptide decoy-loaded hydrogel in mice with bladder outlet obstruction-induced bladder injury
      人氣: 1015, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    62. 2.62
      MP07-02: Therapeutic efficacy of 180-W greenlight xps vaporization of the prostate for the storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors
      人氣: 938, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    63. 2.63
      MP07-03: Factors associated with the usage of alpha-blockers and overactive bladder medicines after transurethral resection of prostate
      人氣: 919, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    64. 2.64
      MP07-04: Preliminary analysis of registered clinical trials for prostatic artery embolization in prostate disease
      人氣: 951, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    65. 2.65
      MP07-05: Does irrigation solution affect visual field clarity during adenoma morcellation in thulium laser enucleation of the prostate: A prospective randomized pilot study
      人氣: 930, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    66. 2.66
      MP07-06: Ureteral access sheath insertion failure and correlation with prediction factors in retrograde intrarenal surgery
      人氣: 903, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    67. 2.67
      MP07-07: Management of renal and proximal ureteral calculi: A three-year single-center experience of retrograde intrarenal surgery
      人氣: 901, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    68. 2.68
      MP07-08: The reason why patient return to emergency department following ureteroscopic lithotripsy
      人氣: 1035, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    69. 2.69
      MP07-09: Transurethral approach for vesicovaginal fistula(VVF) repair?- a less invasive method with preliminary outcome
      人氣: 1107, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    70. 2.70
      MP07-10: Hypertension as a risk factor for urinary retention in the acute stage of the middle cerebral artery stroke
      人氣: 1098, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    71. 2.71
      MP08-01: Hyperthermia enhances chemosensitivity of bladder cancer through epithelial mesenchymal transition suppression
      人氣: 1210, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    72. 2.72
      MP08-02: External validation of pre-operative nomogram for prediction of non-organ confined upper urinary tract urothelial carcinoma in central Taiwan population
      人氣: 920, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    73. 2.73
      MP08-03: The characteristics of end stage renal disease patients with upper urinary tract urothelial cancer treated with radical nephroureterectomy: A single center experience
      人氣: 927, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    74. 2.74
      MP08-04: Investigate the role of neutrophil in different phenotypes of upper tract urothelial carcinoma
      人氣: 938, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    75. 2.75
      MP08-05: Prevalence of chronic kidney disease in upper tract urothelial carcinoma endemic area and its oncological impact in real world
      人氣: 923, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    76. 2.76
      MP08-06: The prognostic impact of tumor location in pT3N0M0 upper urinary tract urothelial carcinoma
      人氣: 923, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    77. 2.77
      MP08-07: Therapeutic outcome of radiation therapy for postoperative locoregional recurrence of upper tract urothelial carcinoma
      人氣: 973, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    78. 2.78
      MP08-08: The impact of nutrition status and comorbidity on the prognosis of upper urinary tract urothelial carcinoma
      人氣: 993, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    79. 2.79
      MP08-09: Comparison of the molecular characteristics of chemical-induced rat interstitial cystitis models
      人氣: 884, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    80. 2.80
      MP08-10: Clinical outcomes of partial resection and replantation of peritoneal dialysis catheter in end stage renal disease patients under continuous ambulatory peritoneal dialysis
      人氣: 914, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
  3. 3.
    Non-Discussion Poster
    1. 3.1
      NDP001: Adrenal cortical carcinoma with IVC/RA thrombus—case report
      人氣: 1078, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    2. 3.2
      NDP002: Results of lenvatinib plus pembrolizumab as neoadjuvant therapy before definite surgery in patients with advanced renal cell carcinoma
      人氣: 1156, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    3. 3.3
      NDP003: Malignant renal epithelioid angiomyolipoma with vaginal and pulmonary metastases – case report
      人氣: 872, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    4. 3.4
      NDP004: Rare differential diagnosis of hemoperitoneum: A case report and review of atraumatic ruptured renal tumor
      人氣: 846, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    5. 3.5
      NDP005: Sporadic extraneural hemangioblastoma associated with polycythemia
      人氣: 880, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    6. 3.6
      NDP006: Bad-luck but good outcome: The clinical implications of synchronous prostate cancer and renal cell carcinoma in 5 cases
      人氣: 906, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    7. 3.7
      NDP007: Malakoplakia in a patient with multiple myeloma – a rare case report
      人氣: 1128, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    8. 3.8
      NDP008: Skin metastasis of renal pelvic squamous cell carcinoma: A case report and literature review
      人氣: 894, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    9. 3.9
      NDP009: Nivolumab and ipilimumab combination therapy in metastasis adrenocortical carcinoma patient: A case report
      人氣: 1041, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    10. 3.10
      NDP010: Renal glomus tumor: A case report and literature review
      人氣: 973, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    11. 3.11
      NDP011: The surgical intervention and outcome of pheochromocytoma crisis: A case series from one single tertiary medical center
      人氣: 880, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    12. 3.12
      NDP012: Silicone granuloma of penis
      人氣: 985, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    13. 3.13
      NDP013: Rare prostatic tumor: Multilocular prostatic cystadenoma
      人氣: 834, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    14. 3.14
      NDP014: Intravascular papillary endothelial hyperplasia (Masson tumor) of testis: Case report
      人氣: 1520, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    15. 3.15
      NDP015: Testicular myeloid sarcoma: A case report
      人氣: 841, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    16. 3.16
      NDP016: Pheochromocytoma with brain metastasis presenting with compressive optic neuropathy--a rare case report
      人氣: 831, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    17. 3.17
      NDP017: Castleman’s disease mimicking renal cell carcinoma: A case report
      人氣: 823, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    18. 3.18
      NDP018: Rare cases report: angiomyolipoma with aggressive behavior of venous invasion
      人氣: 935, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    19. 3.19
      NDP019: Pelvic solitary fibrous tumor- a case report and review of literature
      人氣: 805, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    20. 3.20
      NDP020: Extensive radical surgery and flap reconstruction for recurrent urethra adenocarcinoma: A case report
      人氣: 864, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    21. 3.21
      NDP021: Ureteral paraganglioma: A rare case report
      人氣: 997, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    22. 3.22
      NDP022: Urethral melanoma case presentation and review on latest guidelines
      人氣: 844, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    23. 3.23
      NDP023: Malacoplakia of the urinary bladder with escherichia coli infection: A case report and review of the literature
      人氣: 998, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    24. 3.24
      NDP024: Neuroendocrine carcinoma of urinary bladder in the past ten years in a single hospital- a case series
      人氣: 850, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    25. 3.25
      NDP025: Pheochromocytoma-related takusubo cardiomyopathy during transurethral enucleation of prostate - a case report
      人氣: 881, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    26. 3.26
      NDP026: Malignant sertoli cell tumor of testis: A rare case report
      人氣: 898, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    27. 3.27
      NDP027: An extraordinarily huge retroperitoneal liposarcoma: A case report and literature review
      人氣: 1319, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    28. 3.28
      NDP028: Spermatic cord liposarcoma presenting as recurrent inguinal hernia– a case report
      人氣: 1096, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    29. 3.29
      NDP029: Urachal adenocarcinoma with bone and lung metastases: A rare case report and literature review
      人氣: 984, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    30. 3.30
      NDP030: Dedifferentiated liposarcomas of spermatic cord- a review and case report
      人氣: 896, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    31. 3.31
      NDP031: A 15-year change of adrenal endothelial cyst
      人氣: 1152, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    32. 3.32
      NDP032: A rare case of eosinophilic cystitis mimic urothelial tumor
      人氣: 866, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    33. 3.33
      NDP033: A case report: primary bladder adenocarcinoma with concurrent urachal cyst and adenocarcinoma
      人氣: 836, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    34. 3.34
      NDP034: A rare benign tumor of intrascroal lipoblastoma: a case report and literature review
      人氣: 812, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    35. 3.35
      NDP035: Sertoli cell tumor of testis: Case report and review of the literature
      人氣: 983, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    36. 3.36
      NDP036: Female urethral hemangioma misdiagnosed as a vaginal tumor: A case report and review
      人氣: 949, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    37. 3.37
      NDP037: KCGMH experience and meta-analysis: Comparing PSA response of Abiraterone and Enzalutamide in metastatic castration-resistant prostate cancer in real-world practice
      人氣: 1036, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    38. 3.38
      NDP038: The efficacy of enhanced recovery after surgery (ERAS) in radical prostatectomy
      人氣: 965, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    39. 3.39
      NDP039: The risk factors of the stress urinary incontinence after robotic-assisted laparoscopic radical prostatectomy
      人氣: 1253, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    40. 3.40
      NDP040: Hormone therapy for prostate cancer increased the risk of subsequent hypertension: A nationwide longitudinal cohort study
      人氣: 822, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    41. 3.41
      NDP041: Association between 5α-reductase inhibitors and androgen deprivation therapy
      人氣: 824, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    42. 3.42
      NDP042: The prevalence of port-site incisional hernia after urologic robot-assisted laparoscopic surgery: A single-center retrospective study
      人氣: 797, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    43. 3.43
      NDP043: Comparison of chemotherapy and androgen receptor targeted agents as sequencing treatment in castration resistance prostate cancer
      人氣: 893, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    44. 3.44
      NDP044: Primary malignant melanoma of prostatic urethral: A rare case report and literature review
      人氣: 871, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    45. 3.45
      NDP045: The graft ureteral cancer: A surgical method of graft kidney preservation and planning for future upper tract follow-up
      人氣: 895, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    46. 3.46
      NDP046: Tumor origin of the graft ureteral cancer: From recipient or donor?
      人氣: 935, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    47. 3.47
      NDP047: Urothelial carcinoma recurrence in graft kidney: Case report and literature review
      人氣: 895, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    48. 3.48
      NDP048: Metastatic urothelial carcinoma to skull with significant reossification after pembrolizumab: A case report
      人氣: 971, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    49. 3.49
      NDP049: Extremely rare but rapidly aggressive sarcomatoid urothelial carcinoma: A case report and literature review
      人氣: 805, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    50. 3.50
      NDP050: The postoperative clinical course of bladder cancer with pathological stage T2 low grade after radical cystectomy: A case report of 15-year-outcome
      人氣: 863, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    51. 3.51
      NDP051: Laparoscopic partial cystectomy for the management of urothelial carcinoma in bladder diverticulum
      人氣: 922, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    52. 3.52
      NDP052: Highly invasive and refractory epithelioid angiomyolipoma with liver and lung metastasis: A rare case report and literature review
      人氣: 865, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    53. 3.53
      NDP053: The unusual clinical and image presentation of huge bladder tumor (more than 500 grams) without gross hematuria.
      人氣: 882, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    54. 3.54
      NDP054: The clinical presentation and treatment outcome of Mtor inhibitor in epithelioid angiomyolipoma : A case report and literature review
      人氣: 864, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    55. 3.55
      NDP055: Surgical intervention and immunotherapy for locally advanced plasmacytoid urothelial carcinoma of urinary bladder: A case report
      人氣: 875, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    56. 3.56
      NDP056: Case report: bladder tumor presented with urethral bleeding
      人氣: 870, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    57. 3.57
      NDP057: Fifteen-centimeter-long penile urethral stricture rescued by buccal mucosa graft urethroplasty- a rare case report
      人氣: 917, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    58. 3.58
      NDP058: Endoscopic transurethral fulguration for acute urine retention resulting from a huge bladder diverticulum: A case report
      人氣: 817, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    59. 3.59
      NDP059: Gas explosion during transurethral resection of prostate(TURP) result in bladder rupture: Case report
      人氣: 994, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    60. 3.60
      NDP060: Urolithiasis in unilateral duplex kidney with complete duplicated ureters
      人氣: 991, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    61. 3.61
      NDP061: The application of antegrade flexible ureteroscopy(Furs) for difficult ureter stone scenario: Kidney transplantation and urinary diversion
      人氣: 996, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    62. 3.62
      NDP062: Complete staghorn stone of rotated duplicated-pelvicalyceal horseshoe kidney
      人氣: 1110, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    63. 3.63
      NDP063: Distal ureteral stone in a Studer orthotopic neobladder: A case treated by antegrade flexible cystoscopic and flexible ureteroscopic lithotripsy
      人氣: 934, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    64. 3.64
      NDP064: Pubic hair nidus of bladder stones in a catheterized female patient: A case report and literature review
      人氣: 872, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    65. 3.65
      NDP065: Ureteroscopic lithotripsy related renal pseudoaneurysm- a rare complication after a common operation
      人氣: 927, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    66. 3.66
      NDP066: An adult male ureterocele combines with complicated stone: A case report and literature review
      人氣: 992, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    67. 3.67
      NDP067: Migration of Hem-O-Lok mimicking distal ureteral stone following robotic partial nephrectomy: A case report with review of literature
      人氣: 894, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    68. 3.68
      NDP068: Bladder stone forming on migrated surgical clip ten years after robotic-assisted radical prostatectomy: A case report and literature review
      人氣: 887, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    69. 3.69
      NDP069: Minimal invasive surgery for the treatment of ureteral endometriosis related obstructive uropathy – a single-center experience
      人氣: 889, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    70. 3.70
      NDP070: Chylous ascites after robot-assisted laparoscopic radical prostatectomy
      人氣: 954, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    71. 3.71
      NDP071: V-loc associated intestinal obstruction: A noteworthy cause of postoperative ileus after robotic assisted radical prostatectomy
      人氣: 961, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    72. 3.72
      NDP072: Tuberculous epididymo-orchitis caused by intravesical bacillus calmette-guérin immunotherapy for bladder cancer: A case report
      人氣: 1063, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    73. 3.73
      NDP073: A case report: Xanthogranulomatous cystitis masquerading bladder tumor
      人氣: 1206, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    74. 3.74
      NDP074: Diluted iodine aqueous bladder instillations change the antibiotic susceptibility from multiple drug resistance microorganisms in catheter-associated urinary tract infection
      人氣: 1066, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    75. 3.75
      NDP075: Xanthogranulomatous epididymitis as a rare cause of chronic scrotal pain – case report and review of literature
      人氣: 916, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    76. 3.76
      NDP076: Necrotizing fasciitis after extracorporeal shock wave lithotripsy: A case report
      人氣: 915, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    77. 3.77
      NDP077: Complications of disposable circumcision suture device necessitating surgical intervention: A case series
      人氣: 1446, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    78. 3.78
      NDP078: Urachus fistula: A rare first presentation of appendicitis
      人氣: 1025, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    79. 3.79
      NDP079: Repeat acute pyelonephritis caused by an ureterocele: A case report and literature review
      人氣: 925, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    80. 3.80
      NDP080: Intratesticular hematoma from blunt trauma, a case report about experience of emergency surgical exploration and literature review
      人氣: 995, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    81. 3.81
      NDP081: A bladder-sparing surgical technique for recurrent enterovesical fistula
      人氣: 1114, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    82. 3.82
      NDP082: Traumatic rupture of hydrocele: Case report and review of the literature
      人氣: 1000, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    83. 3.83
      NDP083: Paraganglioma of the urinary bladder: A case report
      人氣: 968, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    84. 3.84
      NDP084: Prolapsed ureterocele causing acute pain and urine retention: A case report
      人氣: 962, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    85. 3.85
      NDP085: Appendix testis torsion in young male with retractile testis and absence blood flow in color doppler ultrasound – a case report
      人氣: 1354, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    86. 3.86
      NDP086: Pulmonary embolism after moderna vaccination in kidney transplant: two-case reports and literature review
      人氣: 941, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    87. 3.87
      NDP087: None A: type renal amyloidosis complicated with staghorn renal stone – a case report
      人氣: 900, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    88. 3.88
      NDP088: Delayed retroperitoneal abscess with cutaneous fistula after nephrectomy with inferior vena cava graft reconstruction: A case report
      人氣: 1199, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    89. 3.89
      NDP089: Scrotal wall ischemia change following the COVID-19 vaccine: A first case report
      人氣: 1163, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    90. 3.90
      NDP090: Right renal infarction after an aortocaval tumor excision – a rare case report
      人氣: 948, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    91. 3.91
      NDP091: Migration of a ventriculo-peritoneal shunt into the urinary bladder- a rare case report and management
      人氣: 1051, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    92. 3.92
      NDP092: The american association F for the surgery of trauma association grade V renal blunt trauma successfully treated conservatively: A case report and imaging sharing
      人氣: 1138, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    93. 3.93
      NDP093: Igg4-related retroperitoneal fibrosis causing ureter stricture and hydronephrosis: A rare case report
      人氣: 1086, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    94. 3.94
      NDP094: Renal arteriovenous fistula presenting with acute pyelonephritis: A rare case report
      人氣: 971, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    95. 3.95
      NDP096: Endometriosis mimic urachal tumor
      人氣: 1019, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    96. 3.96
      NDP097: Kidney laceration after acupuncture and tuina: A case report
      人氣: 1557, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    97. 3.97
      NDP098: Spontaneous renal rupture resulted from severe hydronephrosis associated with ureteral obstruction: A case report
      人氣: 1133, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    98. 3.98
      NDP099: Mantle cell lymphoma initial presenting as bilateral inguinal mass
      人氣: 979, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
    99. 3.99
      NDP100: Solitary fibrous tumor: A rare inguinal tumor
      人氣: 947, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2022-06-07
地址：台北市 11051 信義區基隆路一段432號6樓之1, 電話：02-2729-0819, 傳真：02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw